Global Monoclonal Antibody ADC Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
Monoclonal antibody ADC drug is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies, and a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies.
The Global Monoclonal Antibody ADC Drugs Market Size was estimated at USD 722.91 million in 2023 and is projected to reach USD 1835.45 million by 2029, exhibiting a CAGR of 16.80% during the forecast period.
This report provides a deep insight into the global Monoclonal Antibody ADC Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody ADC Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody ADC Drugs market in any manner.
Global Monoclonal Antibody ADC Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seattle
Roche
Pfizer
AstraZeneca
Immunomedics
GSK
ADC Therapeutics
Lepu Biopharma
Shanghai Junshi Biosciences
RemeGen
Market Segmentation (by Type)
CD30 Target Antigen
HER2 Target Antigen
CD22 Target Antigen
CD33 Target Antigen
Nectin-4 Target Antigen
Others
Market Segmentation (by Application)
Lymphoma
Breast Cancer
Leukemia
Myeloma
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody ADC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Monoclonal antibody ADC drug is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies, and a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies.
The Global Monoclonal Antibody ADC Drugs Market Size was estimated at USD 722.91 million in 2023 and is projected to reach USD 1835.45 million by 2029, exhibiting a CAGR of 16.80% during the forecast period.
This report provides a deep insight into the global Monoclonal Antibody ADC Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody ADC Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody ADC Drugs market in any manner.
Global Monoclonal Antibody ADC Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seattle
Roche
Pfizer
AstraZeneca
Immunomedics
GSK
ADC Therapeutics
Lepu Biopharma
Shanghai Junshi Biosciences
RemeGen
Market Segmentation (by Type)
CD30 Target Antigen
HER2 Target Antigen
CD22 Target Antigen
CD33 Target Antigen
Nectin-4 Target Antigen
Others
Market Segmentation (by Application)
Lymphoma
Breast Cancer
Leukemia
Myeloma
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Monoclonal Antibody ADC Drugs Market
- Overview of the regional outlook of the Monoclonal Antibody ADC Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody ADC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Monoclonal Antibody ADC Drugs
1.2 Key Market Segments
1.2.1 Monoclonal Antibody ADC Drugs Segment by Type
1.2.2 Monoclonal Antibody ADC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY ADC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody ADC Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Monoclonal Antibody ADC Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY ADC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody ADC Drugs Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody ADC Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody ADC Drugs Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody ADC Drugs Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody ADC Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody ADC Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY ADC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody ADC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY ADC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody ADC Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody ADC Drugs Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody ADC Drugs Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody ADC Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Monoclonal Antibody ADC Drugs Sales by Region
8.1.1 Global Monoclonal Antibody ADC Drugs Sales by Region
8.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody ADC Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody ADC Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody ADC Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seattle
9.1.1 Seattle Monoclonal Antibody ADC Drugs Basic Information
9.1.2 Seattle Monoclonal Antibody ADC Drugs Product Overview
9.1.3 Seattle Monoclonal Antibody ADC Drugs Product Market Performance
9.1.4 Seattle Business Overview
9.1.5 Seattle Monoclonal Antibody ADC Drugs SWOT Analysis
9.1.6 Seattle Recent Developments
9.2 Roche
9.2.1 Roche Monoclonal Antibody ADC Drugs Basic Information
9.2.2 Roche Monoclonal Antibody ADC Drugs Product Overview
9.2.3 Roche Monoclonal Antibody ADC Drugs Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Monoclonal Antibody ADC Drugs SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Pfizer
9.3.1 Pfizer Monoclonal Antibody ADC Drugs Basic Information
9.3.2 Pfizer Monoclonal Antibody ADC Drugs Product Overview
9.3.3 Pfizer Monoclonal Antibody ADC Drugs Product Market Performance
9.3.4 Pfizer Monoclonal Antibody ADC Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 AstraZeneca
9.4.1 AstraZeneca Monoclonal Antibody ADC Drugs Basic Information
9.4.2 AstraZeneca Monoclonal Antibody ADC Drugs Product Overview
9.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Product Market Performance
9.4.4 AstraZeneca Business Overview
9.4.5 AstraZeneca Recent Developments
9.5 Immunomedics
9.5.1 Immunomedics Monoclonal Antibody ADC Drugs Basic Information
9.5.2 Immunomedics Monoclonal Antibody ADC Drugs Product Overview
9.5.3 Immunomedics Monoclonal Antibody ADC Drugs Product Market Performance
9.5.4 Immunomedics Business Overview
9.5.5 Immunomedics Recent Developments
9.6 GSK
9.6.1 GSK Monoclonal Antibody ADC Drugs Basic Information
9.6.2 GSK Monoclonal Antibody ADC Drugs Product Overview
9.6.3 GSK Monoclonal Antibody ADC Drugs Product Market Performance
9.6.4 GSK Business Overview
9.6.5 GSK Recent Developments
9.7 ADC Therapeutics
9.7.1 ADC Therapeutics Monoclonal Antibody ADC Drugs Basic Information
9.7.2 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Overview
9.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Market Performance
9.7.4 ADC Therapeutics Business Overview
9.7.5 ADC Therapeutics Recent Developments
9.8 Lepu Biopharma
9.8.1 Lepu Biopharma Monoclonal Antibody ADC Drugs Basic Information
9.8.2 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Overview
9.8.3 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Market Performance
9.8.4 Lepu Biopharma Business Overview
9.8.5 Lepu Biopharma Recent Developments
9.9 Shanghai Junshi Biosciences
9.9.1 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Basic Information
9.9.2 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Overview
9.9.3 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Market Performance
9.9.4 Shanghai Junshi Biosciences Business Overview
9.9.5 Shanghai Junshi Biosciences Recent Developments
9.10 RemeGen
9.10.1 RemeGen Monoclonal Antibody ADC Drugs Basic Information
9.10.2 RemeGen Monoclonal Antibody ADC Drugs Product Overview
9.10.3 RemeGen Monoclonal Antibody ADC Drugs Product Market Performance
9.10.4 RemeGen Business Overview
9.10.5 RemeGen Recent Developments
10 MONOCLONAL ANTIBODY ADC DRUGS MARKET FORECAST BY REGION
10.1 Global Monoclonal Antibody ADC Drugs Market Size Forecast
10.2 Global Monoclonal Antibody ADC Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monoclonal Antibody ADC Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Monoclonal Antibody ADC Drugs Market Size Forecast by Region
10.2.4 South America Monoclonal Antibody ADC Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody ADC Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Monoclonal Antibody ADC Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Monoclonal Antibody ADC Drugs by Type (2025-2030)
11.1.2 Global Monoclonal Antibody ADC Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Monoclonal Antibody ADC Drugs by Type (2025-2030)
11.2 Global Monoclonal Antibody ADC Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Monoclonal Antibody ADC Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Monoclonal Antibody ADC Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Monoclonal Antibody ADC Drugs
1.2 Key Market Segments
1.2.1 Monoclonal Antibody ADC Drugs Segment by Type
1.2.2 Monoclonal Antibody ADC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY ADC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody ADC Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Monoclonal Antibody ADC Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY ADC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody ADC Drugs Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody ADC Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody ADC Drugs Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody ADC Drugs Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody ADC Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody ADC Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY ADC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody ADC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY ADC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody ADC Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody ADC Drugs Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody ADC Drugs Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody ADC Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY ADC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Monoclonal Antibody ADC Drugs Sales by Region
8.1.1 Global Monoclonal Antibody ADC Drugs Sales by Region
8.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody ADC Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody ADC Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody ADC Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seattle
9.1.1 Seattle Monoclonal Antibody ADC Drugs Basic Information
9.1.2 Seattle Monoclonal Antibody ADC Drugs Product Overview
9.1.3 Seattle Monoclonal Antibody ADC Drugs Product Market Performance
9.1.4 Seattle Business Overview
9.1.5 Seattle Monoclonal Antibody ADC Drugs SWOT Analysis
9.1.6 Seattle Recent Developments
9.2 Roche
9.2.1 Roche Monoclonal Antibody ADC Drugs Basic Information
9.2.2 Roche Monoclonal Antibody ADC Drugs Product Overview
9.2.3 Roche Monoclonal Antibody ADC Drugs Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Monoclonal Antibody ADC Drugs SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Pfizer
9.3.1 Pfizer Monoclonal Antibody ADC Drugs Basic Information
9.3.2 Pfizer Monoclonal Antibody ADC Drugs Product Overview
9.3.3 Pfizer Monoclonal Antibody ADC Drugs Product Market Performance
9.3.4 Pfizer Monoclonal Antibody ADC Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 AstraZeneca
9.4.1 AstraZeneca Monoclonal Antibody ADC Drugs Basic Information
9.4.2 AstraZeneca Monoclonal Antibody ADC Drugs Product Overview
9.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Product Market Performance
9.4.4 AstraZeneca Business Overview
9.4.5 AstraZeneca Recent Developments
9.5 Immunomedics
9.5.1 Immunomedics Monoclonal Antibody ADC Drugs Basic Information
9.5.2 Immunomedics Monoclonal Antibody ADC Drugs Product Overview
9.5.3 Immunomedics Monoclonal Antibody ADC Drugs Product Market Performance
9.5.4 Immunomedics Business Overview
9.5.5 Immunomedics Recent Developments
9.6 GSK
9.6.1 GSK Monoclonal Antibody ADC Drugs Basic Information
9.6.2 GSK Monoclonal Antibody ADC Drugs Product Overview
9.6.3 GSK Monoclonal Antibody ADC Drugs Product Market Performance
9.6.4 GSK Business Overview
9.6.5 GSK Recent Developments
9.7 ADC Therapeutics
9.7.1 ADC Therapeutics Monoclonal Antibody ADC Drugs Basic Information
9.7.2 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Overview
9.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Market Performance
9.7.4 ADC Therapeutics Business Overview
9.7.5 ADC Therapeutics Recent Developments
9.8 Lepu Biopharma
9.8.1 Lepu Biopharma Monoclonal Antibody ADC Drugs Basic Information
9.8.2 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Overview
9.8.3 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Market Performance
9.8.4 Lepu Biopharma Business Overview
9.8.5 Lepu Biopharma Recent Developments
9.9 Shanghai Junshi Biosciences
9.9.1 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Basic Information
9.9.2 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Overview
9.9.3 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Market Performance
9.9.4 Shanghai Junshi Biosciences Business Overview
9.9.5 Shanghai Junshi Biosciences Recent Developments
9.10 RemeGen
9.10.1 RemeGen Monoclonal Antibody ADC Drugs Basic Information
9.10.2 RemeGen Monoclonal Antibody ADC Drugs Product Overview
9.10.3 RemeGen Monoclonal Antibody ADC Drugs Product Market Performance
9.10.4 RemeGen Business Overview
9.10.5 RemeGen Recent Developments
10 MONOCLONAL ANTIBODY ADC DRUGS MARKET FORECAST BY REGION
10.1 Global Monoclonal Antibody ADC Drugs Market Size Forecast
10.2 Global Monoclonal Antibody ADC Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monoclonal Antibody ADC Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Monoclonal Antibody ADC Drugs Market Size Forecast by Region
10.2.4 South America Monoclonal Antibody ADC Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody ADC Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Monoclonal Antibody ADC Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Monoclonal Antibody ADC Drugs by Type (2025-2030)
11.1.2 Global Monoclonal Antibody ADC Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Monoclonal Antibody ADC Drugs by Type (2025-2030)
11.2 Global Monoclonal Antibody ADC Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Monoclonal Antibody ADC Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Monoclonal Antibody ADC Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody ADC Drugs Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody ADC Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody ADC Drugs as of 2022)
Table 10. Global Market Monoclonal Antibody ADC Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody ADC Drugs Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody ADC Drugs Product Type
Table 13. Global Monoclonal Antibody ADC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody ADC Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody ADC Drugs Market Challenges
Table 22. Global Monoclonal Antibody ADC Drugs Sales by Type (Kilotons)
Table 23. Global Monoclonal Antibody ADC Drugs Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody ADC Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody ADC Drugs Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody ADC Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Application
Table 30. Global Monoclonal Antibody ADC Drugs Market Size by Application
Table 31. Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody ADC Drugs Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Seattle Monoclonal Antibody ADC Drugs Basic Information
Table 44. Seattle Monoclonal Antibody ADC Drugs Product Overview
Table 45. Seattle Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Seattle Business Overview
Table 47. Seattle Monoclonal Antibody ADC Drugs SWOT Analysis
Table 48. Seattle Recent Developments
Table 49. Roche Monoclonal Antibody ADC Drugs Basic Information
Table 50. Roche Monoclonal Antibody ADC Drugs Product Overview
Table 51. Roche Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Monoclonal Antibody ADC Drugs SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Pfizer Monoclonal Antibody ADC Drugs Basic Information
Table 56. Pfizer Monoclonal Antibody ADC Drugs Product Overview
Table 57. Pfizer Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Monoclonal Antibody ADC Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. AstraZeneca Monoclonal Antibody ADC Drugs Basic Information
Table 62. AstraZeneca Monoclonal Antibody ADC Drugs Product Overview
Table 63. AstraZeneca Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Recent Developments
Table 66. Immunomedics Monoclonal Antibody ADC Drugs Basic Information
Table 67. Immunomedics Monoclonal Antibody ADC Drugs Product Overview
Table 68. Immunomedics Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Immunomedics Business Overview
Table 70. Immunomedics Recent Developments
Table 71. GSK Monoclonal Antibody ADC Drugs Basic Information
Table 72. GSK Monoclonal Antibody ADC Drugs Product Overview
Table 73. GSK Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GSK Business Overview
Table 75. GSK Recent Developments
Table 76. ADC Therapeutics Monoclonal Antibody ADC Drugs Basic Information
Table 77. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Overview
Table 78. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ADC Therapeutics Business Overview
Table 80. ADC Therapeutics Recent Developments
Table 81. Lepu Biopharma Monoclonal Antibody ADC Drugs Basic Information
Table 82. Lepu Biopharma Monoclonal Antibody ADC Drugs Product Overview
Table 83. Lepu Biopharma Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lepu Biopharma Business Overview
Table 85. Lepu Biopharma Recent Developments
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Basic Information
Table 87. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Overview
Table 88. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai Junshi Biosciences Business Overview
Table 90. Shanghai Junshi Biosciences Recent Developments
Table 91. RemeGen Monoclonal Antibody ADC Drugs Basic Information
Table 92. RemeGen Monoclonal Antibody ADC Drugs Product Overview
Table 93. RemeGen Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. RemeGen Business Overview
Table 95. RemeGen Recent Developments
Table 96. Global Monoclonal Antibody ADC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Monoclonal Antibody ADC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Monoclonal Antibody ADC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Monoclonal Antibody ADC Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Monoclonal Antibody ADC Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Monoclonal Antibody ADC Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody ADC Drugs Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody ADC Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody ADC Drugs as of 2022)
Table 10. Global Market Monoclonal Antibody ADC Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody ADC Drugs Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody ADC Drugs Product Type
Table 13. Global Monoclonal Antibody ADC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody ADC Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody ADC Drugs Market Challenges
Table 22. Global Monoclonal Antibody ADC Drugs Sales by Type (Kilotons)
Table 23. Global Monoclonal Antibody ADC Drugs Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody ADC Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody ADC Drugs Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody ADC Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) by Application
Table 30. Global Monoclonal Antibody ADC Drugs Market Size by Application
Table 31. Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody ADC Drugs Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Seattle Monoclonal Antibody ADC Drugs Basic Information
Table 44. Seattle Monoclonal Antibody ADC Drugs Product Overview
Table 45. Seattle Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Seattle Business Overview
Table 47. Seattle Monoclonal Antibody ADC Drugs SWOT Analysis
Table 48. Seattle Recent Developments
Table 49. Roche Monoclonal Antibody ADC Drugs Basic Information
Table 50. Roche Monoclonal Antibody ADC Drugs Product Overview
Table 51. Roche Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Monoclonal Antibody ADC Drugs SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Pfizer Monoclonal Antibody ADC Drugs Basic Information
Table 56. Pfizer Monoclonal Antibody ADC Drugs Product Overview
Table 57. Pfizer Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Monoclonal Antibody ADC Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. AstraZeneca Monoclonal Antibody ADC Drugs Basic Information
Table 62. AstraZeneca Monoclonal Antibody ADC Drugs Product Overview
Table 63. AstraZeneca Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Recent Developments
Table 66. Immunomedics Monoclonal Antibody ADC Drugs Basic Information
Table 67. Immunomedics Monoclonal Antibody ADC Drugs Product Overview
Table 68. Immunomedics Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Immunomedics Business Overview
Table 70. Immunomedics Recent Developments
Table 71. GSK Monoclonal Antibody ADC Drugs Basic Information
Table 72. GSK Monoclonal Antibody ADC Drugs Product Overview
Table 73. GSK Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GSK Business Overview
Table 75. GSK Recent Developments
Table 76. ADC Therapeutics Monoclonal Antibody ADC Drugs Basic Information
Table 77. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Overview
Table 78. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ADC Therapeutics Business Overview
Table 80. ADC Therapeutics Recent Developments
Table 81. Lepu Biopharma Monoclonal Antibody ADC Drugs Basic Information
Table 82. Lepu Biopharma Monoclonal Antibody ADC Drugs Product Overview
Table 83. Lepu Biopharma Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lepu Biopharma Business Overview
Table 85. Lepu Biopharma Recent Developments
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Basic Information
Table 87. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Overview
Table 88. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai Junshi Biosciences Business Overview
Table 90. Shanghai Junshi Biosciences Recent Developments
Table 91. RemeGen Monoclonal Antibody ADC Drugs Basic Information
Table 92. RemeGen Monoclonal Antibody ADC Drugs Product Overview
Table 93. RemeGen Monoclonal Antibody ADC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. RemeGen Business Overview
Table 95. RemeGen Recent Developments
Table 96. Global Monoclonal Antibody ADC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Monoclonal Antibody ADC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Monoclonal Antibody ADC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Monoclonal Antibody ADC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Monoclonal Antibody ADC Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Monoclonal Antibody ADC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Monoclonal Antibody ADC Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Monoclonal Antibody ADC Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Monoclonal Antibody ADC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody ADC Drugs Market Size (M USD), 2019-2030
Figure 5. Global Monoclonal Antibody ADC Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody ADC Drugs Market Size by Country (M USD)
Figure 11. Monoclonal Antibody ADC Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody ADC Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody ADC Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody ADC Drugs Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody ADC Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody ADC Drugs by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody ADC Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody ADC Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody ADC Drugs Market Share by Application
Figure 24. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody ADC Drugs Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody ADC Drugs Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Monoclonal Antibody ADC Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody ADC Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Monoclonal Antibody ADC Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Monoclonal Antibody ADC Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Monoclonal Antibody ADC Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Monoclonal Antibody ADC Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Monoclonal Antibody ADC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody ADC Drugs Market Size (M USD), 2019-2030
Figure 5. Global Monoclonal Antibody ADC Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Monoclonal Antibody ADC Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody ADC Drugs Market Size by Country (M USD)
Figure 11. Monoclonal Antibody ADC Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody ADC Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody ADC Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody ADC Drugs Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody ADC Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody ADC Drugs by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody ADC Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody ADC Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody ADC Drugs Market Share by Application
Figure 24. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody ADC Drugs Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody ADC Drugs Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody ADC Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Monoclonal Antibody ADC Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody ADC Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Monoclonal Antibody ADC Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Monoclonal Antibody ADC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Monoclonal Antibody ADC Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Monoclonal Antibody ADC Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Monoclonal Antibody ADC Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Monoclonal Antibody ADC Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Monoclonal Antibody ADC Drugs Market Share Forecast by Application (2025-2030)
